After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…
Naked Mole-Rats’ Long Life Due to Better DNA Repair Mechanisms
Naked mole-rats are well known for both their wrinkly appearance and for their unexpectedly long lives. The source…
Naked Mole-Rats’ Long Life Due to Better DNA Repair Mechanisms
Naked mole-rats are well known for both their wrinkly appearance and for their unexpectedly long lives. The source…
Next-generation gene therapy tools built by UH scientist
Reading time: 2 minutesAssistant Professor Jesse Owens using a program to model the structure of his integrase protein.…
Bridge Recombinase Platform Enables Megabase-Scale Human Genome Rearrangements
For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting…
A more precise way to edit the genome | MIT News
A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into…
Genome Editing Market Forecast Report 2025-2030, with Profiles of Merck, Horizon Discovery, GenScript, Sangamo Therapeutics, Danaher, Lonza, BEX, OriGene Technologies, CRISPR Therapeutics, and More
Company Logo Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and…
AI enables precise gene editing
A research team led by the University of Zurich (UZH) has developed a powerful new method to precisely…
Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment
Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…
Now Hear This: New Study Compares Gene Therapy and Cochlear Implants
By: Staff Writer | August 07, 2025 | 5 min. read | Share Summary Dr. Xue Zhong Liu was…
Japan’s Genome Editing Market Set to Reach USD 1.45 Billion by 2033
Company Logo Japan’s genome editing market, valued at USD 1.45 billion by 2033, grows at a 17.97% CAGR,…